article thumbnail

New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue

The Pharma Data

15, 2021 — An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds. Right now, no medication is approved specifically for pulmonary hypertension caused by ILD, said Dr. Steven Nathan, senior researcher on the new trial. FRIDAY, Jan.

Doctors 52
article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part ii)

pharmaphorum

Elliott informed those in attendance that for the next five years, with about £5 billion in funding for pipelines across a network of research and institute centres in clinical trials, that the aim is for everyone to live a life free of cancer. And in the UK over 30% of clinical trials funded has one European partner at least.

Nurses 97